AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-3,978 Cr | ₹-3,212 Cr | ₹599 Cr | ₹-1,568 Cr | ₹-2,903 Cr |
What is the latest Cash Flow from Investing Activities ratio of AUROBINDO PHARMA ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2023 | ₹-3,978 Cr |
Mar2022 | ₹-3,212 Cr |
Mar2021 | ₹599 Cr |
Mar2020 | ₹-1,568 Cr |
Mar2019 | ₹-2,903 Cr |
How is Cash Flow from Investing Activities of AUROBINDO PHARMA Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-3,978 Cr | Negative | |
Mar2022 | ₹-3,212 Cr | Negative | |
Mar2021 | ₹599 Cr | Positive | |
Mar2020 | ₹-1,568 Cr | Negative | |
Mar2019 | ₹-2,903 Cr | - |
Compare Cash Flow from Investing Activities of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹67,536.7 Cr | 4.6% | 5.9% | 86.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1% | -5% | 53.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 4.6% |
5.9% |
86.7% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses